AC
RPTP

Armistice Capital’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Armistice Capital’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-130,000
Closed -$1.41M – 40
2015
Q1 		$1.41M Sell
130,000
-670,000
-84% -$6.84M 0.63% 24
2014
Q4 		$8.42M Buy
+800,000
New +$7.82M 4.04% 12

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Armistice Capital's RPTP Position: Q2 2015 in Review

Armistice Capital sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2015, closing a stake of 130,000 shares — an estimated $1.41M sold.

Armistice Capital first reported a position in RPTP in Q4 2014 and held it in 2 quarters. The position peaked at $8.42M in Q4 2014. 100 funds tracked by Wall St. Rank hold RPTP as of Q2 2015.

  • Armistice Capital reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Armistice Capital sold 130,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q2 2015, an estimated $1.41M.
  • Armistice Capital first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Armistice Capital's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $8.42M in Q4 2014.
  • 100 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2015.

Based on Armistice Capital's 13F filing for Q2 2015, filed 14 Aug 2015.